Contact | Search on Europa   

Infectious Diseases Graphic element print icon Graphic element
  Homepage
Graphic element General information
  RTD Infectious Diseases Unit
  Developing countries
  EDCTP
   
Graphic element Projects
  About FP6 Funding
  FP6 projects
  About FP5 Funding
  FP5 projects
   
   
Graphic element Addressed Diseases
  HIV/AIDS
- News
  Malaria
- News
  Tuberculosis
   
Graphic element Calls for proposals
  FP7 Calls
  Call Evaluation
   
Graphic element Contact corner
  Unit
  Scientific officers
  Subscribe to our mailing list
   
 
The 1st FP7 call has closed.
The 2nd FP7 call has been published - deadline 18/09/2007.

Subscribe to our mailing list to receive up-to-date information.


HIV/AIDS, Malaria and Tuberculosis

Under the area ‘HIV/AIDS, malaria and tuberculosis’ research will focus on developing new therapies, diagnostic tools, and preventive tools such as vaccines and chemicals barriers as HIV microbicides. Research efforts will confront the three diseases at global level, but will also address specific European aspects of the three diseases as hepatitis co-infection. Preclinical and early clinical research activities will be emphasised.

Open Calls

Topics for second call Deadline 18 September 2007

  • Network on HIV and anti HIV drug resistance
    Funding scheme: Collaborative projects (large-scale Integrating projects)
  • HIV and hepatitis co-infection
    Funding scheme: Coordination and Support action
  • Blocking the transmission of malaria: the mosquito vector target
    Funding scheme: Collaborative Projects (small or medium-scale focused research projects)
  • European network for study and clinical management of TB drug resistance
    Funding scheme: Collaborative projects (large-scale Integrating projects)
  • Support platform for the development of PRD vaccines
    Funding scheme: Coordination and Support action

Topics for specific International cooperation action (SICA) - Deadline 18 September 2007

  • Highly innovative research in HIV/AIDS, malaria and tuberculosis between Indian and European partners
    Funding scheme: Collaborative Projects (small or medium-scale focused research projects)
  • Coordination of European research activities with global initiatives, including Public-Private Partnerships
    Funding scheme: Coordination and Support action
  • Next Generation of researchers for HIV/AIDS, malaria, tuberculosis and neglected infectious diseases
    Funding scheme: Coordination and Support action

Closed Calls

Topics for first call

  • HIV/AIDS Drug Discovery and Preclinical Development
  • Highly Innovative approaches for research into host pathogen interaction in tuberculosis
  • Development of fast tests for the diagnosis of Multi-Drug Resistant strains of HIV, malaria and tuberculosis, and of latent tuberculosis infection.
  • Addressing knowledge gaps in pregnancy malaria
  • Funding scheme: Collaborative Projects (small or medium-scale focused research projects)
  • Paediatric formulation of drugs against HIV/AIDS, malaria and tuberculosis
  • Funding scheme: Coordination and Support action
  • New HIV Vaccines inducing broadly-reactive neutralising antibodies
    Funding scheme: Collaborative projects (large scale Integrating projects)

contact

Manuel Romaris Infectious Diseases Unit
manuel.romaris@ec.europa.eu / Tel +32 2 2998733

Hannu Laang Infectious Diseases Unit
hannu.laang@ec.europa.eu / Tel +32 2 2969602

Neglected Infectious Diseases

Under the area ‘Neglected Infectious Diseases’, research will focus on an integrated approach for the development of preventive, therapeutic and control tools for neglected infectious diseases: diseases caused by Trypanosomatidae species and a wider range of vector-borne diseases, as well as other neglected infectious diseases, including childhood infections.

Topics for specific International cooperation action (SICA) Deadline 18 September 2007

  • Development of new tools to control infections due to parasites of the Trypanosomatidae family.
  • Development of a Leishmania vaccine
  • Bio prospecting for drug leads
    Funding scheme: Collaborative Projects (small or medium scale focused research projects)

contact

Andreas Holtel Infectious Diseases Unit
andreas.holtel@ec.europa.eu / Tel +32 2 2953716

Ole Olesen Infectious Diseases Unit
ole.olesen@ec.europa.eu / Tel +32 2 2953999

Anti-microbial drug resistance including fungal pathogens

The strategic objective of 'anti-microbial drug resistance' is to confront the increasing emergence and spread of microbial drug resistant pathogens in Europe and the rest of the world at broad fronts and in a multidisciplinary approach through the development of effective infection prevention and control strategies.

Topics for Second call - Deadline 18 September 2007

  • Novel targets for drugs against Gram negative bacteria
    Funding scheme: Collaborative Projects (small or medium-scale focused research projects with maximum contribution of 6.000.000/project)
  • Host-pathogen interactions in infections by Streptococcus pneumoniae
    Funding scheme: Collaborative Projects (small or medium-scale focused research projects)
  • An integrated platform for development and clinical evaluation of point-of-care diagnostic devices for microbial detection, antibiotic susceptibility determination and biomarkers
    Funding scheme: Collaborative Projects (large scale Integrating projects)

  • Molecular epidemiology to control nosocomial and community spreading of highly virulent multi-drug resistant strains of bacterial pathogens.
    Funding scheme: Collaborative Projects (small or medium-scale focused research projects)
  • Health and economic cost of antimicrobial resistance
    Funding scheme:Coordination and Support action
  • Conference on genetic and biochemical tools for postgenomic physiological analysis of Staphylococcus, in particular MRSA
    Funding scheme: Coordination and Support action

Potentially new and re-emerging epidemics

The area related to 'Potentially new and re-emerging epidemics' intends to confront emerging pathogens with pandemic potential including zoonoses (e.g. SARS and highly pathogenic influenza). Call topics aim to cover the full' value chain' of health research: from innovative basic research to early stage clinical trials of new prevention, diagnostic and therapeutic measures all the way to implementation research supporting effective public health responses.

Topics for Second call - Deadline 18 September 2007

  • Strengthening research on prediction, identification, modelling and surveillance of newly emerging infectious diseases in humans
    Funding scheme: Collaborative projects (large-scale integrating projects)

  • Definition of research needs and priorities in Europe in the area of Emerging Infectious Epidemics
    Funding scheme: Coordination and Support action

Contact

Anna Lönnroth - Infectious Diseases Unit
Tel: +32 (0)2 29-94210 - anna.lonnroth@ec.europa.eu

Cornelius Schmaltz - Infectious Diseases Unit
Tel: +32 (0)2 29-58984 - cornelius.schmaltz@ec.europa.eu

For more information

 
 
top
Graphic element